Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GABAPENTIN Cause Condition aggravated? 2,264 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 2,264 reports of Condition aggravated have been filed in association with GABAPENTIN (Gabapentin). This represents 3.0% of all adverse event reports for GABAPENTIN.

2,264
Reports of Condition aggravated with GABAPENTIN
3.0%
of all GABAPENTIN reports
226
Deaths
781
Hospitalizations

How Dangerous Is Condition aggravated From GABAPENTIN?

Of the 2,264 reports, 226 (10.0%) resulted in death, 781 (34.5%) required hospitalization, and 207 (9.1%) were considered life-threatening.

Is Condition aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GABAPENTIN. However, 2,264 reports have been filed with the FAERS database.

What Other Side Effects Does GABAPENTIN Cause?

Drug ineffective (10,914) Drug hypersensitivity (6,833) Off label use (6,729) Drug ineffective for unapproved indication (5,231) Product use in unapproved indication (4,919) Toxicity to various agents (4,839) Completed suicide (4,111) Dizziness (4,107) Somnolence (3,798) Fatigue (3,791)

What Other Drugs Cause Condition aggravated?

TOFACITINIB (16,925) INFLIXIMAB (16,616) DUPILUMAB (16,459) ETANERCEPT (15,897) METHOTREXATE (14,938) ADALIMUMAB (13,527) PREDNISONE (10,751) INFLIXIMAB-DYYB (10,275) HYDROXYCHLOROQUINE (8,848) RITUXIMAB (8,627)

Which GABAPENTIN Alternatives Have Lower Condition aggravated Risk?

GABAPENTIN vs GABAPENTIN ENACARBIL GABAPENTIN vs GADAVIST GABAPENTIN vs GADOBENATE DIMEGLUMINE GABAPENTIN vs GADOBUTROL GABAPENTIN vs GADODIAMIDE

Related Pages

GABAPENTIN Full Profile All Condition aggravated Reports All Drugs Causing Condition aggravated GABAPENTIN Demographics